High-impact drugs such as topicals and combo packs often see low utilization, but carry exponentially higher costs. While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for potential benefits to injured workers, as they may provide relief that traditional therapies cannot. (Credit: Kenishirotie/Stock.adobe.com)

When we talk about addressing pharmacy issues in workers’ compensation programs, opioid concerns often appear at the top of the agenda, and while opioid management remains an important focus, it is not the only pharmacy trend we must watch closely.

High-impact categories such as topicals, compound kits, combo packs, and specialty medications represent proportionately low utilization, however, they can be associated with exponentially higher costs. In order to effectively manage clinically appropriate utilization and savings within these classes, it is important to recognize the trends associated with each of these cost drivers.

Want to continue reading?
Become a Free
PropertyCasualty360 Digital Reader.

INCLUDED IN A DIGITAL MEMBERSHIP:

  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.

Already have an account?

 

PropertyCasualty360

Join PropertyCasualty360

Don’t miss crucial news and insights you need to make informed decisions for your P&C insurance business. Join PropertyCasualty360.com now!

  • Unlimited access to PropertyCasualty360.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including BenefitsPRO.com, ThinkAdvisor.com and Law.com
  • Exclusive discounts on PropertyCasualty360, National Underwriter, Claims and ALM events

Already have an account? Sign In Now
Join PropertyCasualty360

Copyright © 2022 ALM Global, LLC. All Rights Reserved.